Buy (150 RUB)
|Generate QR code
Open Access
Subscription or Fee Access
Analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region
https://doi.org/10.33667/2078-5631-2025-1-30-33
Abstract
Currently, there are numerous reports in the world and in Russia about a serious complication of the new coronavirus infection – extensive damage to the soft tissue and bone structures of the middle zone of the face. This complication is polyethological in nature and is caused by immunosuppression due to the severe course of COVID-19, high doses of glucocorticosteroids, hyperglycemia, against which an opportunistic infectious necrotic process develops a second time caused by various microorganisms, including fungi of the genus Mucorales, as well as various bacterial flora. The article provides an analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region, which were isolated as a result of microbiological research, namely Klebsiella pneumonia and Streptococcus viridans. The main criteria for choosing antimicrobial therapy for this pathology are also formulated.
About the Authors
S. O. Ivanyuta
Stavropol State Medical University Ministry of Health of Russia
Russian Federation
Russian Federation
S.O. Ivanyuta, graduate student of the Department of Surgical Dentistry and Maxillofacial Surgery
D. Y. Hristoforando
Stavropol State Medical University Ministry of Health of Russia; City clinical hospital of emergency medical care
Russian Federation
Russian Federation
D.Y. Hristoforando, Dr. Sci. (Med.), professor of The Department of Surgical Dentistry and Maxillofacial Surgery; Head of the Department of Maxillofacial Surgery
E. M. Spevak
Stavropol State Medical University Ministry of Health of Russia; City clinical hospital of emergency medical care
Russian Federation
Russian Federation
E.M. Spevak, Cand. Sci. (Med.), Assistant of the Department of Surgical Dentistry and Maxillofacial Surgery; maxillofacial surgeon of the Department of Maxillofacial Surgery
References
1. Slavkova N, Nedevska M. Aseptic osteonecrosis of the maxilla after severe COVID-19 infection and its treatment. Radiol Case Rep. 2022;17(9):3228-3232. DOI: 10.1016/j.radcr.2022.06.009.
2. Ivanyuta S.O., Hristoforando D.Y., Spevak E.M., Tsymbal A.N. Postcovid necrosis of the cranio-maxillofacial region. Kazan medical journal. 2023;104(4):552–563. (In Russ.) doi: 10.17816/KMJ119997
3. Sood A., Nayyar V., Roychoudhury A., Bhalla A.S., Mishra D. Post-COVID steroid induced avascular necrosis of the jaw: Emerging challenge in India. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. 2022:S2212-4403(22)01122-1. DOI: 10.1016/j.oooo.2022.08.014.
4. Hoenigl M., Seidel D., Carvalho A., Rudramurthy S.M., [et al.]; ECMM and ISHAM collaborators. The emergence of COVID-19 associated mucormycosis: a review of cases from 18 countries. Lancet Microbe. 2022;3(7):543–552. DOI: 10.1016/S2666-5247(21)00237-8.
5. Kuzmina E.V., Borovoy V.N., Sotnikova M.V., Lis E.S., Dovgan E.V., Kovalkova P.A. Diagnosis of rhinocerebral mucormycosis as complication of COVID-19, features of patient’s treatment. Clinical Dentistry (Russia). 2022; 25(2):82–92 (In Russ.) DOI: 10.37988/1811-153X_2022_2_82.
6. Khostelidi S.N., Zaytsev V.A., Vartanyan S.A., Nikitin N.A. [et al.] Mucormycosis in patients with COVID-19 in Russia: the results of a prospective multi-center study. Journal Infectology. 2022;14(2):116–127. (In Russ.) DOI: 10.22625/2072-6732-2022-14-2-116-127.
7. Baranova I.B., Yaremenko A.I., Zubareva A.A., Karpischenko S.A. [et al.] Mucormycosis of the bones of the facial skull, nasal cavity and par anasal sinuses in patients with COVID-19. Clinical Microbiology and Antimicrobial Chemotherapy. 2021;23(4):347–358. (In Russ.) DOI: 10.36488/cmac.2021.4.347-358.
8. Volodina V.D., Babkova A.A., Serova N.S., Reshetov I.V. Fungal osteomyelitis of the skull in patients after COVID-19 associated pneumonia. Head and neck. Russian magazine = Head and neck. Russian Journal. 2022;10(3):53–59. (In Russ.) DOI 10.25792/HN.2022.10.3.53-59.
9. Sen M., Honavar S.G., Bansal R., Sengupta S. [et al.]; members of the Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC) Study Group. Epidemiology, clinical profile, management, and outcome of COVID-19-associated rhino-orbital-cerebral mucormycosis in 2826 patients in India – Collaborative OPAI-IJO Study on Mucormycosis in COVID-19 (COSMIC), Report 1. Indian J Ophthalmol. 2021;69(7):1670–1692. DOI: 10.4103/ijo.IJO_1565_21.
10. Suresh A., Joshi A., Desai A.K., Juturu U. [et al.] Covid-19-associated fungal osteomyelitis of jaws and sinuses: An experience-driven management protocol. Med Mycol. 2022;60(2):myab082. DOI: 10.1093/mmy/myab082.
Review
For citations:
Ivanyuta S.O., Hristoforando D.Y., Spevak E.M. Analysis of the sensitivity to antibacterial drugs of the most significant microorganisms in postcovoid lesions of the maxillofacial region. Medical alphabet. 2025;(1):30-33. (In Russ.) https://doi.org/10.33667/2078-5631-2025-1-30-33
Views:
129
Email this article 